Pre-transplant renal impairment predicts posttransplant cardiac events in patients with liver cirrhosis

Transplantation

Volumn 98, Issue 1, 2014, Pages 107-114

  Josefsson, Axel ^a   Fu, Michael ^a   Björnsson, Einar ^b   Castedal, Maria ^a   Kalaitzakis, Evangelos ^a,c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiac events; Liver cirrhosis; Liver transplantation; Prolonged QT interval; Renal impairment

Indexed keywords

CHROMIUM 51; EDETIC ACID;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE FAILURE; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; QT INTERVAL; RETRANSPLANTATION;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; DISEASE-FREE SURVIVAL; FEMALE; GLOMERULAR FILTRATION RATE; HEART DISEASES; HEART RATE; HUMANS; KIDNEY; KIDNEY DISEASES; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84903759740     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000442781.31885.a2     Document Type: Article

References (42)

1. Plotkin JS, Benitez RM, Kuo PC, et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg 1998; 4: 253.
2. Berzigotti A, Bonfiglioli A, Muscari A, et al. Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis. Liver Int 2005; 25: 331.
3. Patel S, Kiefer TL, Ahmed A, et al. Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease. Am J Cardiol 2011; 108: 1552.
4. Josefsson A, Fu M, Allayhari P, et al. Impact of peri-transplant heart failure & left-ventricular diastolic dysfunction on outcomes following liver transplantation. Liver Int 2012; 32: 1262.
5. EleidMF, Hurst RT, VargasHE, et al. Short-term cardiac and noncardiac mortality following liver transplantation. J Transplant 2010; 2010.
6. Fouad TR, Abdel-Razek WM, Burak KW, et al. Prediction of cardiac complications after liver transplantation. Transplantation 2009; 87: 763.
7. Safadi A, Homsi M, Maskoun W, et al. Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation 2009; 120: 1189.
8. Prakash J, Mahapatra AK, Ghosh B, et al. Clinical spectrum of renal disorders in patients with cirrhosis of liver. Ren Fail 2011; 33: 40.
9. Gonwa TA, Morris CA, Goldstein RM, et al. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndromeYexperience in 300 patients. Transplantation 1991; 51: 428.
10. Di Angelantonio E, Chowdhury R, Sarwar N, et al. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ 2010; 341: c4986.
11. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034.
12. Wong F, Girgrah N, Graba J, et al. The cardiac response to exercise in cirrhosis. Gut 2001; 49: 268.
13. Genovesi S, Prata Pizzala DM, Pozzi M, et al. QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium. Clin Sci (Lond) 2009; 116: 851.
14. Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2009; 31: 703.
15. Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527.
16. National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1.
17. Kadayifci A, Tan V, Ursell PC, et al. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies. J Hepatol 2008; 49: 595.
18. Kalaitzakis E, Bjornsson E. Coronary artery disease in liver cirrhosis: does the aetiology of liver disease matter? J Hepatol 2009; 51: 962; author reply 963Y4.
19. Kalaitzakis E, Rosengren A, Skommevik T, et al. Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci 2009; 55: 467.
20. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296.
21. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 1179.
22. Gonwa TA, McBride MA, Anderson K, et al. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant 2006; 6: 2651.
23. Bernal V, Pascual I, Piazuelo E, et al. Cystatin C level as a predictor of death and cardiovascular events after liver transplantation. Transplant Proc 2011; 43: 732.
24. Morard I, Mentha G, Spahr L, et al. Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels. Clin Transplant 2006; 20: 96.
25. Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009; 361: 1279.
26. Ruiz-del-Arbol L,Monescillo A, Arocena C, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005; 42: 439.
27. Finucci G, Lunardi F, Sacerdoti D, et al. Q-T interval prolongation in liver cirrhosis. Reversibility after orthotopic liver transplantation. Jpn Heart J 1998; 39: 321.
28. Elming H, Brendorp B, Kober L, et al. QTc interval in the assessment of cardiac risk. Card Electrophysiol Rev 2002; 6: 289.
29. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993; 72: 23B.
30. Hage FG, de Mattos AM, Khamash H, et al. QT prolongation is an independent predictor of mortality in end-stage renal disease. Clin Cardiol 2010; 33: 361.
31. Moller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol 2010; 53: 179.
32. Bal JS, Thuluvath PJ. Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int 2003; 23: 243.
33. Day CP, James OF, Butler TJ, et al. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 1993; 341: 1423.
34. Puthumana L, Chaudhry V, Thuluvath PJ. Prolonged QTc interval and its relationship to autonomic cardiovascular reflexes in patients with cirrhosis. J Hepatol 2001; 35: 733.
35. Cazzaniga M, Salerno F, Pagnozzi G, et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut 2007; 56: 869.
36. Rabie RN, Cazzaniga M, Salerno F, et al. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 2009; 104: 2458.
37. Rincon D, Lo Iacono O, Tejedor M, et al. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis. Scand J Gastroenterol 2013; 48: 487.
38. Singh M, Rihal CS, Selzer F, et al. Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry. J Am Coll Cardiol 2003; 42: 1722.
39. Singh M, Lennon RJ, Holmes DR Jr, et al. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol 2002; 40: 387.
40. Steyerberg EW, Bleeker SE, Moll HA, et al. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 2003; 56: 441.
41. Zambruni A, Trevisani F, Di Micoli A, et al. Effect of chronic betablockade on QT interval in patients with liver cirrhosis. J Hepatol 2008; 48: 415.
42. Adam R, Cailliez V, Majno P, et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 2000; 356: 621.